294 related articles for article (PubMed ID: 12507780)
1. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation.
Mahon BD; Gordon SA; Cruz J; Cosman F; Cantorna MT
J Neuroimmunol; 2003 Jan; 134(1-2):128-32. PubMed ID: 12507780
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.
Åivo J; Hänninen A; Ilonen J; Soilu-Hänninen M
J Neuroimmunol; 2015 Mar; 280():12-5. PubMed ID: 25773149
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency is associated with inflammatory cytokine concentrations in patients with diabetic foot infection.
Tiwari S; Pratyush DD; Gupta SK; Singh SK
Br J Nutr; 2014 Dec; 112(12):1938-43. PubMed ID: 25331710
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial.
Waterhouse M; Tran B; Ebeling PR; English DR; Lucas RM; Venn AJ; Webb PM; Whiteman DC; Neale RE
Br J Nutr; 2015 Sep; 114(5):693-9. PubMed ID: 26206095
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity.
Rasa F; Naderi N; Eftekhar E; Mansoori E; Rahimzadeh M
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):522-529. PubMed ID: 29701163
[TBL] [Abstract][Full Text] [Related]
8. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
[TBL] [Abstract][Full Text] [Related]
9. Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-beta levels after fish oil supplementation of pregnant women.
Krauss-Etschmann S; Hartl D; Rzehak P; Heinrich J; Shadid R; Del Carmen Ramírez-Tortosa M; Campoy C; Pardillo S; Schendel DJ; Decsi T; Demmelmair H; Koletzko BV;
J Allergy Clin Immunol; 2008 Feb; 121(2):464-470.e6. PubMed ID: 17980419
[TBL] [Abstract][Full Text] [Related]
10. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 but not transforming growth factor-β1 gene expression is up-regulated by vitamin D treatment in multiple sclerosis patients.
Farsani ZS; Behmanesh M; Sahraian MA
J Neurol Sci; 2015 Mar; 350(1-2):18-23. PubMed ID: 25680585
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Khodadadi B; Jazayeri S; Gohari MR; Aryaeian N
Nutr Neurosci; 2015 May; 18(4):169-76. PubMed ID: 24621064
[TBL] [Abstract][Full Text] [Related]
13. The effect of retinyl-palmitate on the level of pro and anti-inflammatory cytokines in multiple sclerosis patients: A randomized double blind clinical trial.
Bitarafan S; Mohammadpour Z; Jafarirad S; Harirchian MH; Yekaninejad MS; Saboor-Yaraghi AA
Clin Neurol Neurosurg; 2019 Feb; 177():101-105. PubMed ID: 30640138
[TBL] [Abstract][Full Text] [Related]
14. [Pathogenesis and therapy of multiple sclerosis. The role of cytokines].
Weber F; Rieckmann P
Nervenarzt; 1995 Feb; 66(2):150-5. PubMed ID: 7715757
[TBL] [Abstract][Full Text] [Related]
15. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta 1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis.
Link J; He B; Navikas V; Palasik W; Fredrikson S; Söderström M; Link H
J Neuroimmunol; 1995 Apr; 58(1):21-35. PubMed ID: 7537278
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D supplementation of low birth weight term Indian infants from birth on cytokine production at 6 months.
Trilok-Kumar G; Arora H; Rajput M; Chellani H; Singh V; Raynes J; Arya S; Aggarwal S; Srivastava N; Sachdev HP; Filteau S
Eur J Clin Nutr; 2012 Jun; 66(6):746-50. PubMed ID: 22510791
[TBL] [Abstract][Full Text] [Related]
18. Supplemental vitamin D increases serum cytokines in those with initially low 25-hydroxyvitamin D: a randomized, double blind, placebo-controlled study.
Barker T; Rogers VE; Levy M; Templeton J; Goldfine H; Schneider ED; Dixon BM; Henriksen VT; Weaver LK
Cytokine; 2015 Feb; 71(2):132-8. PubMed ID: 25461390
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effects of Vitamin D in multiple sclerosis.
Correale J; Ysrraelit MC; Gaitán MI
Brain; 2009 May; 132(Pt 5):1146-60. PubMed ID: 19321461
[TBL] [Abstract][Full Text] [Related]
20. A study of five human cytokine genes in human essential hypertension.
Frossard PM; Gupta A; Pravica V; Perrey C; Hutchinson IV; Lukic ML
Mol Immunol; 2002 May; 38(12-13):969-76. PubMed ID: 12009575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
